Search Results

There are 11860 results for: content related to: Correlations between the percentage of tumor cells showing an anaplastic lymphoma kinase ( ALK ) gene rearrangement, ALK signal copy number, and response to crizotinib therapy in ALK fluorescence in situ hybridization–positive nonsmall cell lung cancer

  1. You have full text access to this Open Access content
    Echinoderm microtubule-associated protein-like 4–anaplastic lymphoma kinase-targeted therapy for advanced non-small cell lung cancer: Molecular and clinical aspects

    Cancer Science

    Volume 103, Issue 8, August 2012, Pages: 1391–1396, Isamu Okamoto and Kazuhiko Nakagawa

    Version of Record online : 17 JUN 2012, DOI: 10.1111/j.1349-7006.2012.02327.x

  2. You have full text access to this OnlineOpen article
    Sufficiency of Single-Arm Studies to Support Registration of Targeted Agents in Molecularly Selected Patients with Cancer: Lessons from the Clinical Development of Crizotinib

    Clinical and Translational Science

    Volume 9, Issue 2, April 2016, Pages: 63–73, P Selaru, Y Tang, B Huang, A Polli, KD Wilner, E Donnelly and DP Cohen

    Version of Record online : 1 MAR 2016, DOI: 10.1111/cts.12388

  3. You have full text access to this OnlineOpen article
    Complex renal cysts associated with crizotinib treatment

    Cancer Medicine

    Volume 4, Issue 6, June 2015, Pages: 887–896, Patrick Schnell, Cynthia H. Bartlett, Benjamin J. Solomon, Vanessa Tassell, Alice T. Shaw, Tommaso de Pas, Soo-Hyun Lee, Geon Kook Lee, Kaoru Tanaka, Weiwei Tan, Yiyun Tang, Keith D. Wilner, Allan Safferman and Ji-Youn Han

    Version of Record online : 10 MAR 2015, DOI: 10.1002/cam4.437

  4. You have free access to this content
    Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer

    Cancer

    Volume 118, Issue 21, 1 November 2012, Pages: 5302–5309, Andrew J. Weickhardt, Micol S. Rothman, Smita Salian-Mehta, Katja Kiseljak-Vassiliades, Ana B. Oton, Robert C. Doebele, Margaret E. Wierman and D. Ross Camidge

    Version of Record online : 4 APR 2012, DOI: 10.1002/cncr.27450

  5. You have full text access to this OnlineOpen article
    Is there a progression-free survival benefit of first-line crizotinib versus standard chemotherapy and second-line crizotinib in ALK-positive advanced lung adenocarcinoma? A retrospective study of Chinese patients

    Cancer Medicine

    Volume 5, Issue 6, June 2016, Pages: 1013–1021, Shaohua Cui, Yizhuo Zhao, Lili Dong, Aiqin Gu, Liwen Xiong, Jialin Qian, Wei Zhang, Yanjie Niu, Feng Pan and Liyan Jiang

    Version of Record online : 16 FEB 2016, DOI: 10.1002/cam4.659

  6. Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALKFISH probe testing

    Histopathology

    Volume 67, Issue 5, November 2015, Pages: 654–663, Christina Selinger, Wendy Cooper, Trina Lum, Catriona McNeil, Adrienne Morey, Paul Waring, Benhur Amanuel, Michael Millward, Joanne Peverall, Chris Van Vliet, Michael Christie, Yen Tran, Connie Diakos, Nick Pavlakis, Anthony J Gill and Sandra O'Toole

    Version of Record online : 24 MAY 2015, DOI: 10.1111/his.12708

  7. Current Status of Targeted Therapy for Anaplastic Lymphoma Kinase–Rearranged Non–Small Cell Lung Cancer

    Clinical Pharmacology & Therapeutics

    Volume 95, Issue 1, January 2014, Pages: 15–23, B Solomon, KD Wilner and AT Shaw

    Version of Record online : 19 DEC 2013, DOI: 10.1038/clpt.2013.200

  8. You have full text access to this OnlineOpen article
    Amphiregulin triggered epidermal growth factor receptor activation confers in vivo crizotinib-resistance of EML4-ALK lung cancer and circumvention by epidermal growth factor receptor inhibitors

    Cancer Science

    Volume 108, Issue 1, January 2017, Pages: 53–60, Hirokazu Taniguchi, Shinji Takeuchi, Koji Fukuda, Takayuki Nakagawa, Sachiko Arai, Shigeki Nanjo, Tadaaki Yamada, Hiroyuki Yamaguchi, Hiroshi Mukae and Seiji Yano

    Version of Record online : 30 DEC 2016, DOI: 10.1111/cas.13111

  9. You have free access to this content
    Native and rearranged ALK copy number and rearranged cell count in non–small cell lung cancer

    Cancer

    Volume 119, Issue 22, 15 November 2013, Pages: 3968–3975, D. Ross Camidge, Margaret Skokan, Porntip Kiatsimkul, Barbara Helfrich, Xian Lu, Anna E. Barón, Nathan Schulte, DeLee Maxson, Dara L. Aisner, Wilbur A. Franklin, Robert C. Doebele and Marileila Varella-Garcia

    Version of Record online : 10 SEP 2013, DOI: 10.1002/cncr.28311

  10. You have free access to this content
    Diagnostic assays for identification of anaplastic lymphoma kinase-positive non–small cell lung cancer

    Cancer

    Volume 119, Issue 8, 15 April 2013, Pages: 1467–1477, Andrew J. Weickhardt, Dara L. Aisner, Wilbur A. Franklin, Marileila Varella-Garcia, Robert C. Doebele and D. Ross Camidge

    Version of Record online : 20 DEC 2012, DOI: 10.1002/cncr.27913

  11. Characteristics and outcomes of ALK+ non-small cell lung cancer patients in Korea

    Asia-Pacific Journal of Clinical Oncology

    Sung Hee Lim, Kyung Ah Yoh, Jong Seok Lee, Myung-ju Ahn, Yu Jung Kim, Se Hyun Kim, Jie Zhang, Dony Patel, Elyse Swallow, Andrew Kageleiry, Philip Galebach, Dongyeol Lee, Karen Stein, Ravi Degun and Keunchil Park

    Version of Record online : 16 APR 2017, DOI: 10.1111/ajco.12645

  12. Optimizing Treatment for Patients With Anaplastic Lymphoma Kinase-Positive Lung Cancer

    Clinical Pharmacology & Therapeutics

    Volume 101, Issue 5, May 2017, Pages: 625–633, I Dagogo-Jack, AT Shaw and GJ Riely

    Version of Record online : 17 MAR 2017, DOI: 10.1002/cpt.653

  13. Clinical features of Bim deletion polymorphism and its relation with crizotinib primary resistance in Chinese patients with ALK/ROS1 fusion-positive non-small cell lung cancer

    Cancer

    Limin Zhang, Tao Jiang, Xuefei Li, Yan Wang, Chao Zhao, Sha Zhao, Lei Xi, Shijia Zhang, Xiaozhen Liu, Yijun Jia, Hui Yang, Jinpeng Shi, Chunxia Su, Shengxiang Ren and Caicun Zhou

    Version of Record online : 27 MAR 2017, DOI: 10.1002/cncr.30677

  14. You have free access to this content
    Symptomatic reduction in free testosterone levels secondary to crizotinib use in male cancer patients

    Cancer

    Volume 119, Issue 13, 01 July 2013, Pages: 2383–2390, Andrew J. Weickhardt, Robert C. Doebele, W. Thomas Purcell, Paul A. Bunn, Ana B. Oton, Micol S. Rothman, Margaret E. Wierman, Tony Mok, Sanjay Popat, Julie Bauman, Jorge Nieva, Silvia Novello, Sai-Hong Ignatius Ou and D. Ross Camidge

    Version of Record online : 12 APR 2013, DOI: 10.1002/cncr.28089

  15. You have free access to this content
    Heart rate decrease during crizotinib treatment and potential correlation to clinical response

    Cancer

    Volume 119, Issue 11, 1 June 2013, Pages: 1969–1975, Sai-Hong Ignatius Ou, Wilson P. Tong, Michele Azada, Christina Siwak-Tapp, Joni Dy and Jonathan A. Stiber

    Version of Record online : 15 MAR 2013, DOI: 10.1002/cncr.28040

  16. Evaluation of crizotinib absolute bioavailability, the bioequivalence of three oral formulations, and the effect of food on crizotinib pharmacokinetics in healthy subjects

    The Journal of Clinical Pharmacology

    Volume 55, Issue 1, January 2015, Pages: 104–113, Huiping Xu, Melissa O'Gorman, Tanya Boutros, Nicoletta Brega, Constantino Kantaridis, Weiwei Tan and Akintunde Bello

    Version of Record online : 10 JUL 2014, DOI: 10.1002/jcph.356

  17. You have full text access to this OnlineOpen article
    Pharmacokinetic profiles of significant adverse events with crizotinib in Japanese patients with ABCB1 polymorphism

    Cancer Science

    Volume 107, Issue 8, August 2016, Pages: 1117–1123, Yutaka Fujiwara, Akinobu Hamada, Hidenori Mizugaki, Hiroaki Aikawa, Toshiyuki Hata, Hidehito Horinouchi, Shintaro Kanda, Yasushi Goto, Kota Itahashi, Hiroshi Nokihara, Noboru Yamamoto and Yuichiro Ohe

    Version of Record online : 21 JUL 2016, DOI: 10.1111/cas.12983

  18. You have full text access to this OnlineOpen article
    Pharmacologic study (JP28927) of alectinib in Japanese patients with ALK+ non-small-cell lung cancer with or without prior crizotinib therapy

    Cancer Science

    Volume 107, Issue 11, November 2016, Pages: 1642–1646, Toyoaki Hida, Kazuhiko Nakagawa, Takashi Seto, Miyako Satouchi, Makoto Nishio, Katsuyuki Hotta, Toshiaki Takahashi, Yuichiro Ohe, Koji Takeda, Masahiro Tatsuno, Takashi Asakawa, Tadashi Shimada, Tomohiro Tanaka and Tomohide Tamura

    Version of Record online : 29 NOV 2016, DOI: 10.1111/cas.13066

  19. You have free access to this content
    Lung cancer with translocation in the anaplastic lymphoma kinase gene

    Cancer

    Volume 118, Issue 18, 15 September 2012, Pages: 4370–4371, Suresh S. Ramalingam and Fadlo R. Khuri

    Version of Record online : 26 JAN 2012, DOI: 10.1002/cncr.27402

  20. You have full text access to this OnlineOpen article
    In vivo imaging models of bone and brain metastases and pleural carcinomatosis with a novel human EML4-ALK lung cancer cell line

    Cancer Science

    Volume 106, Issue 3, March 2015, Pages: 244–252, Shigeki Nanjo, Takayuki Nakagawa, Shinji Takeuchi, Kenji Kita, Koji Fukuda, Mitsutoshi Nakada, Hisanori Uehara, Hiroshi Nishihara, Eiji Hara, Hidetaka Uramoto, Fumihiro Tanaka and Seiji Yano

    Version of Record online : 17 FEB 2015, DOI: 10.1111/cas.12600